Vanguard Personalized Indexing Management LLC Has $834,000 Stock Holdings in Bruker Corporation $BRKR

Vanguard Personalized Indexing Management LLC lifted its holdings in Bruker Corporation (NASDAQ:BRKR) by 96.2% in the 2nd quarter, Holdings Channel.com reports. The firm owned 20,230 shares of the medical research company’s stock after buying an additional 9,918 shares during the quarter. Vanguard Personalized Indexing Management LLC’s holdings in Bruker were worth $834,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of the business. Pinnacle Bancorp Inc. bought a new stake in Bruker in the 1st quarter valued at approximately $29,000. Allworth Financial LP raised its stake in Bruker by 92.4% in the 1st quarter. Allworth Financial LP now owns 758 shares of the medical research company’s stock valued at $30,000 after acquiring an additional 364 shares during the period. Caitong International Asset Management Co. Ltd raised its stake in Bruker by 1,354.5% in the 1st quarter. Caitong International Asset Management Co. Ltd now owns 800 shares of the medical research company’s stock valued at $33,000 after acquiring an additional 745 shares during the period. Parallel Advisors LLC raised its stake in Bruker by 63.0% in the 2nd quarter. Parallel Advisors LLC now owns 898 shares of the medical research company’s stock valued at $37,000 after acquiring an additional 347 shares during the period. Finally, Annis Gardner Whiting Capital Advisors LLC bought a new stake in Bruker in the 1st quarter valued at $42,000. 79.52% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of research analysts have commented on BRKR shares. Barclays decreased their price objective on Bruker from $43.00 to $40.00 and set an “overweight” rating on the stock in a report on Thursday, October 2nd. Bank of America reduced their price objective on Bruker from $61.00 to $50.00 and set a “buy” rating on the stock in a research note on Thursday, June 26th. Citigroup reduced their price objective on Bruker from $40.00 to $38.00 and set a “neutral” rating on the stock in a research note on Monday, August 4th. Jefferies Financial Group set a $60.00 target price on Bruker and gave the company a “buy” rating in a research report on Monday, August 4th. Finally, Wells Fargo & Company dropped their target price on Bruker from $60.00 to $50.00 and set an “overweight” rating for the company in a research report on Tuesday, August 5th. Five equities research analysts have rated the stock with a Buy rating, five have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $51.00.

Bruker Trading Down 3.2%

NASDAQ BRKR opened at $36.98 on Monday. The business has a 50 day simple moving average of $33.48 and a 200 day simple moving average of $36.98. Bruker Corporation has a one year low of $28.53 and a one year high of $64.64. The stock has a market capitalization of $5.61 billion, a P/E ratio of 71.12, a P/E/G ratio of 5.18 and a beta of 1.20. The company has a debt-to-equity ratio of 1.31, a current ratio of 1.61 and a quick ratio of 0.70.

Bruker (NASDAQ:BRKR) last announced its quarterly earnings data on Monday, August 4th. The medical research company reported $0.32 EPS for the quarter, missing analysts’ consensus estimates of $0.33 by ($0.01). Bruker had a net margin of 2.31% and a return on equity of 17.89%. The firm had revenue of $797.40 million during the quarter, compared to analyst estimates of $811.17 million. During the same period last year, the business posted $0.52 EPS. The company’s revenue was down .4% on a year-over-year basis. Bruker has set its FY 2025 guidance at 1.950-2.050 EPS. Research analysts expect that Bruker Corporation will post 2.69 earnings per share for the current year.

Bruker Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, October 3rd. Shareholders of record on Tuesday, September 23rd were paid a $0.05 dividend. This represents a $0.20 dividend on an annualized basis and a yield of 0.5%. The ex-dividend date of this dividend was Tuesday, September 23rd. Bruker’s dividend payout ratio (DPR) is 38.46%.

Insider Buying and Selling

In related news, Director Cynthia M. Friend sold 3,535 shares of Bruker stock in a transaction that occurred on Friday, September 12th. The stock was sold at an average price of $32.25, for a total transaction of $114,003.75. Following the transaction, the director owned 18,016 shares of the company’s stock, valued at $581,016. The trade was a 16.40% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Company insiders own 27.30% of the company’s stock.

Bruker Company Profile

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.